Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.2437 EUR
−39.46 M EUR
2.56 M EUR
19.73 M
About Dianthus Therapeutics, Inc.
Sector
Industry
CEO
Marino Garcia
Website
Headquarters
New York
Founded
2015
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of A3ERZ4 is 22.6000 EUR — it has increased by 7.62% in the past 24 hours. Watch Dianthus Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Dianthus Therapeutics, Inc. stocks are traded under the ticker A3ERZ4.
A3ERZ4 stock has risen by 24.86% compared to the previous week, the month change is a 0.89% rise, over the last year Dianthus Therapeutics, Inc. has showed a 11.88% increase.
We've gathered analysts' opinions on Dianthus Therapeutics, Inc. future price: according to them, A3ERZ4 price has a max estimate of 76.99 EUR and a min estimate of 33.00 EUR. Watch A3ERZ4 chart and read a more detailed Dianthus Therapeutics, Inc. stock forecast: see what analysts think of Dianthus Therapeutics, Inc. and suggest that you do with its stocks.
A3ERZ4 reached its all-time high on Feb 17, 2025 with the price of 23.6000 EUR, and its all-time low was 19.6000 EUR and was reached on Jan 23, 2025. View more price dynamics on A3ERZ4 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
A3ERZ4 stock is 7.41% volatile and has beta coefficient of 1.20. Track Dianthus Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Dianthus Therapeutics, Inc. there?
Today Dianthus Therapeutics, Inc. has the market capitalization of 660.28 M, it has increased by 0.89% over the last week.
Yes, you can track Dianthus Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Dianthus Therapeutics, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
A3ERZ4 earnings for the last quarter are −0.78 EUR per share, whereas the estimation was −0.82 EUR resulting in a 4.76% surprise. The estimated earnings for the next quarter are −0.78 EUR per share. See more details about Dianthus Therapeutics, Inc. earnings.
Dianthus Therapeutics, Inc. revenue for the last quarter amounts to 1.28 M EUR, despite the estimated figure of 922.72 K EUR. In the next quarter, revenue is expected to reach 936.33 K EUR.
A3ERZ4 net income for the last quarter is −22.61 M EUR, while the quarter before that showed −16.44 M EUR of net income which accounts for −37.55% change. Track more Dianthus Therapeutics, Inc. financial stats to get the full picture.
No, A3ERZ4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 12, 2025, the company has 53.00 employees. See our rating of the largest employees — is Dianthus Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dianthus Therapeutics, Inc. EBITDA is −74.07 M EUR, and current EBITDA margin is −1.69 K%. See more stats in Dianthus Therapeutics, Inc. financial statements.
Like other stocks, A3ERZ4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dianthus Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.